Cancer Genetics, Inc. Receives New York State Licensure for FHACT Cervical Cancer Test
April 16, 2015 at 07:46 AM EDT
Cancer Genetics, Inc. (Nasdaq: CGIX) ("CGI" or "The Company"), an emerging leader in DNA-based cancer diagnostics, announced today that ...